BNP Paribas Knock-Out EUR/GBP 20..../ DE000PC3MG04 /
| 14/06/2024 13:21:11 | Var.-0.090 | Denaro13:29:43 | Lettera13:29:43 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
|---|---|---|---|---|---|---|---|
| 13.420EUR | -0.67% | 13.410 Quantità in denaro: 15,000 |
13.420 Quantità in lettera: 15,000 |
- | 0.96 GBP | 20/09/2024 | Put |
GlobeNewswire
13:30
JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Note...
GlobeNewswire
13:30
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evalua...
GlobeNewswire
13:30
Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective an...
GlobeNewswire
13:30
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Associatio...
GlobeNewswire
13:30
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Associatio...
GlobeNewswire
13:14
Hymson Brings its Laser Solutions for Battery Innovation to The Battery Show Europe 2024
GlobeNewswire
13:01
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 V...
GlobeNewswire
13:00
Correction: 仙境传说：破晓 (Ragnarok: Dawn, Tentative English Title) Received an ISBN from the Chinese Gove...
GlobeNewswire
13:00
Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-3...
GlobeNewswire
13:00
Volvo Car Canada Collaborates with iconic global fashion brand to unveil curated looks inspired by t...
GlobeNewswire
13:00
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter ...
GlobeNewswire
13:00
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in ...
GlobeNewswire
13:00
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatmen...
